ArticleResearch square2025
Increasing participation of underrepresented groups in cancer early detection research: a scoping review.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
4 authors.
Funding
Abstract
Background: Improvements in access to early-detection research on cancer are still urgently needed to ensure that new research on early-stage cancer detection benefits all groups in society. To achieve this, cancer early detection (ED) studies must include participants from all walks of life. There are unique aspects to cancer early detection research that may deter potential research participants and complicate efforts to involve people from underrepresented backgrounds that require a review on its own merit. For instance, a unique risk for cancer ED research is overdiagnosis and overtreatment, in which a tumour is uncovered and treated that would not have led to the patient's death if left undiscovered and untreated. This potential 'side effect' of cancer ED research participation is particularly problematic for those without adequate access to healthcare and insurance. Methods: Contributing to a growing literature on approaches to increase diversity in cancer detection research, we conducted a targeted scoping review to identify published approaches that have been implemented and tested, either quantitatively or qualitatively, to improve participation of minoritised groups in cancer ED research. Results: This review identifies themes in the 38 included studies that aimed to recruit and involve participants from underserved groups in cancer ED research so that future studies may learn from or further test these varied strategies. We narratively group the review in terms of the barriers identified, and the approaches that have been designed to improve participation. These include rethinking recruitment locations and partnerships with local communities, designing educational interventions, combining research with community needs, increasing cultural competence of research teams, and overcoming practical barriers in study design. Conclusions: This scoping literature review highlights various tools, empirically tested, that research teams can employ to improve participation rates of groups underrepresented in cancer ED research. Combinations of these methods can help overcome the perceived barriers to participation in cancer research that mainly affect people without a cancer diagnosis from these minoritised groups. Not only will these methods increase the generalizability and representativeness of studies; the highlighted approaches also contribute to a more significant shift in research culture towards less extractive and more trusting relationships between researchers and the public.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.